Científicos del Cima y de la Clínica Universidad de Navarra describen el sistema inmune en pacientes con mieloma múltiple a través de muestras de sangre. Los cambios inmunológicos observados infl...
Read moreUn estudio revela cómo el material genético de las células saludables cercanas a los tumores puede ayudar a anticipar posibles reapariciones de esta enfermedad. Los investigadores pudieron identifi...
Read moreUn equipo del CSIC describe un mecanismo para controlar la formación de lazos de ADN por las proteínas llamadas cohesinas, implicadas en procesos cancerígenos y en enfermedades raras
Read moreA study by the Clínic-IDIBAPS shows that silencing this gene reduces the growth of liver cancer in mice. The research, using different animal models, confirms that the Dhx15 gene is essential for the...
Read moreResearchers from IRSJD · SJD Barcelona Children's Hospital and IRB Barcelona have successfully developed Drosophila models expressing the EWS-FLI oncogene at varying levels, overcoming previous toxic...
Read moreThis tool, named Optimal XR, aims to prevent potentially malignant lung nodules that are currently not diagnosed in time from continuing to go unnoticed
Read moreNew perspectives to better understand how the molecular mechanisms involved in regenerative medicine work. The study focuses on tumour necrosis factor-α (TNF-α) and its receptors TNFR, molecules of ...
Read moreThermo Fisher Scientific Inc., the world leader in serving science, today announced it has been 510k cleared, following US Food and Drug Administration (FDA) requirements, to market its Optilite® Fre...
Read moreRecopilan a través de dispositivos o aplicaciones móviles, datos sobre las rutinas diarias de pacientes con cáncer de mama que están en tratamiento con quimioterapia o radioterapia. La finalidad e...
Read moreThe study, which has been published in the scientific journal ‘Journal of Experimental & Clinical Cancer Research’, shows that the ITGAV protein allows a better stratification of patients and reve...
Read moreR&D investments of € 4.6 million were made, of which € 4.2 million in development and € 0.4 million in research. Following the completion of the PORTICO clinical trial, the R&D investment intens...
Read moreLa compañía aumenta su facturación en un 5% en la primera mitad del año respecto al mismo periodo del 2023, impulsada por el crecimiento de todas sus áreas de negocio, destacando especialmente el...
Read more